HORUS AG O.N./ DE0005204127 /
| 2024-04-19 5:15:02 PM | Chg. 0.000 | Volume | Bid10:00:02 PM | Ask10:00:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.200EUR | 0.00% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 3.33 mill.EUR | 0.00% | 3.29 |
GlobeNewswire
2022-03-02
4biddenknowledge Inc. Releases the First NFT in Their Much-Anticipated Line of NFTs 'The 4bidden Pan...
GlobeNewswire
2021-08-24
Alimera Sciences Announces National Pricing and Reimbursement Granted for ILUVIEN® for DME in Belgiu...
GlobeNewswire
2020-08-26
Alimera Sciences Announces National Reimbursement Granted for ILUVIEN® in the Netherlands
GlobeNewswire
2019-12-03
Alimera Announces Regulatory Approval for ILUVIEN® in Benelux Countries for The Treatment of Non-Inf...
GlobeNewswire
2019-09-12
Alimera Announces Expansion of Agreement with Distribution Partner Horus Pharma to Include Marketing...
GlobeNewswire
2017-08-29
Alimera Sciences Signs Agreement for Exclusive Distributor of ILUVIEN® in France
